Why the study?
Does warfarin or aspirin prescription at hospital discharge reduce death or ischemic events in Medicare beneficiaries with chronic nonvalvular atrial fibrillation?
Does warfarin or aspirin prescription at hospital discharge reduce death or ischemic events in Medicare beneficiaries with chronic nonvalvular atrial fibrillation?
In elderly Medicare beneficiaries with chronic NVAF, warfarin prescription at discharge is associated with a significant reduction in death or ischemic events, highlighting the adverse consequences of its underuse.
No takes yet. Share an insight, caveat, or question.
Warfarin at discharge may warrant consideration in elderly NVAF; leaves open need for randomized confirmation in Medicare cohorts.
Gage et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: